As 2022 draws to a close, we’re celebrating a record-breaking year at Missouri Partnership by taking a look back at some of Missouri’s biggest stories in economic development from the past year. Today, we are highlighting Wugen’s expansion in St. Louis, Missouri.
In March, Wugen, a St. Louis, Missouri-based biotechnology startup, announced plans to expand in St. Louis’ Cortex Innovation Community.
“We’re proud to see cutting-edge companies like Wugen starting up and succeeding right here in our state,” said Governor Mike Parson. “The Cortex Innovation Community in St. Louis demonstrates the strength of the region’s growing high-tech sector and continues to support innovation while helping create high-paying jobs for Missourians. Wugen is another example of a Missouri-made company improving the lives of people right here at home and around the globe, and we’re eager to see its continued growth.”
The expansion is expected to create 100 new jobs in the region.
“We are excited to stay within the Cortex Innovation Community,” Dan Kemp, President and CEO of Wugen, said. “We are proud to be part of St. Louis’ vibrant biotech community and are pleased to continue to grow locally, where we will have the opportunity to maintain proximity to our world-class scientific co-founders at Washington University and build on our existing partnerships with the area’s premier scientific institutions. Our new space will give us more room to grow, accelerating our mission of delivering best-in-class, off-the-shelf cell therapies to cancer patients.”
Check out our full coverage here.